ATP128 vaccine with ezabenlimab promotes antigen-specific immune responses in stage IV colorectal cancer in the KISIMA-01 phase 1b trial.Heinz-Josef Lenz, Hanz Prenen,Eric Van Cutsem,Thibaud Koessler,Jean-Francois Mayol,Francesca Trapani,Matthieu Tihy,Laura Rubbia-Brandt,Christian Toso,Thomas Bogenrieder,Elodie Belnoue,Madiha Derouazi,Scott KopetzCANCER RESEARCH（2022）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
